Drug intelligence / Profile preview

oxetacaine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Oxetacaine is a potent local anesthetic and antacid used primarily for the relief of pain associated with gastrointestinal conditions such as gastritis, peptic ulcer disease, heartburn, esophagitis, and hiatus hernia. It is typically administered orally in combination with antacids (such as aluminum hydroxide and magnesium hydroxide) to provide both mucosal anesthesia and acid neutralization. Oxetacaine acts by inhibiting gastric acid secretion through suppression of gastrin secretion and exerts a strong local anesthetic effect on the gastric mucosa by blocking nerve conduction via inhibition of sodium ion permeability in nerve membranes. Its unique chemical properties allow it to remain effective even in acidic environments where other local anesthetics may degrade. Oxetacaine is reported to be significantly more potent than lignocaine or cocaine as a local anesthetic.

Brand names
Mucaine
Other names
oxetacaineoxethazaine
02

Targets

SCN3A (Sodium channel protein type 3 subunit alpha)

Beyond the preview

Go deeper on oxetacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxetacaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call